Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study

Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study

Abstract Background Regular users of aspirin may have reduced risk of breast cancer. Few studies have addressed whether risk reduction pertains to specific breast cancer subtypes defined jointly by hormone receptor (estrogen and progesterone receptor) and human epidermal growth factor receptor 2 (HE...

Full description

Bibliographic Details
Main Authors: Christina A. Clarke, Alison J. Canchola, Lisa M. Moy, Susan L. Neuhausen, Nadia T. Chung, James V. Lacey, Leslie Bernstein
Format: Article
Language:English
Published: BMC 2017-05-01
Series:Breast Cancer Research
Subjects:
Aspirin
NSAIDs
Breast cancer
Hormone receptor
HER2
Subtype
Online Access:http://link.springer.com/article/10.1186/s13058-017-0840-7

Internet

http://link.springer.com/article/10.1186/s13058-017-0840-7

Similar Items